22 May 2013
Keywords: gsk, who-tdr, medicines, malaria, venture, act, accord
Article | 03 May 2004
GlaxoSmithKline, the World Health Organization's Special Programme for Research and Training in Tropical Diseases (WHO-TDR) and the Medicines
for Malaria ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 May 2004
21 May 2013
© 2013 thepharmaletter.com